Literature DB >> 23071263

Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer.

A Thiery-Vuillemin1, E Curtit2, T Maurina2, D Montange3, C Succi4, T NGuyen2, S Kim2, P Montcuquet2, X Pivot5, B Royer6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23071263     DOI： 10.1093/annonc/mds477

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

2.  Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report.

Authors:  Manabu Takai; Koji Kameyama; Shohei Toyota; Shingo Kamei; Shigeaki Yokoi; Satoshi Ishihara; Takashi Deguchi
Journal:  IJU Case Rep       Date:  2019-07-09

Review 3.  Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.

Authors:  Łukasz Mielczarek; Anna Brodziak; Paweł Sobczuk; Maciej Kawecki; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Cancer Chemother Pharmacol       Date:  2021-03-25       Impact factor: 3.333

4.  Pharmacokinetics of gefitinib in a patient with non-small cell lung cancer undergoing continuous ambulatory peritoneal dialysis.

Authors:  Teppei Yamaguchi; Sumito Isogai; Takuya Okamura; Sakurako Uozu; Yuki Mieno; Tami Hoshino; Yasuhiro Goto; Masamichi Hayashi; Toru Nakanishi; Kazuyoshi Imaizumi
Journal:  Case Rep Oncol       Date:  2015-02-11

Review 5.  Treatment of patients with metastatic renal cell carcinoma undergoing hemodialysis: case report of two patients and short literature review.

Authors:  John Syrios; Georgios Kechagias; Nicolas Tsavaris
Journal:  BMC Nephrol       Date:  2013-04-12       Impact factor: 2.388

Review 6.  Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review.

Authors:  M P Brizzi; A La Salvia; M Tampellini; C Sonetto; M Volante; G V Scagliotti
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.